Search

… patients receiving immune checkpoint inhibitors.   Joseph Barbi, PhD , Assistant Professor of Oncology in Roswell … patients, we hope to inspire future studies,” says Dr. Barbi. “We believe our findings provide a rationale for … clinical and preclinical observations, Drs. Yendamuri and Barbi designed a  phase 2 clinical trial (NCT04931017) to …

… at Roswell Park Comprehensive Cancer Center, and Joseph Barbi, PhD , Assistant Professor, Department of Immunology. … at Roswell Park Comprehensive Cancer Center, and Joseph Barbi, PhD , Assistant Professor, Department of Immunology. …

… of Oncology, Department of Thoracic Surgery, and  Joseph Barbi, PhD , Assistant Professor of Oncology, Department of … cancer cells. In preclinical studies carried out in Dr. Barbi’s group, indeed, a combination of metformin and … of Oncology, Department of Thoracic Surgery, and  Joseph Barbi, PhD , Assistant Professor of Oncology, Department of …

… Yendamuri, MD, FACS , Mary Reid, PhD, MSPH , and Joseph Barbi, PhD , earned a $3.1 million R01 award from the NCI to … Yendamuri, MD, FACS , Mary Reid, PhD, MSPH , and Joseph Barbi, PhD , earned a $3.1 million R01 award from the NCI to …

… in the pancreatic cancer tumor microenvironment   Joseph Barbi, PhD , Obesity dependent benefits of metformin for … in the pancreatic cancer tumor microenvironment   Joseph Barbi, PhD , Obesity dependent benefits of metformin for …

… of Oncology, Department of Thoracic Surgery, and Joseph Barbi, PhD , Assistant Professor of Oncology, Department of … of Oncology, Department of Thoracic Surgery, and Joseph Barbi, PhD , Assistant Professor of Oncology, Department of …